Purple Biotech Ltd
PPBT
$2.25
$0.000.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.52M | 7.39M | 15.41M | 16.08M | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 275.00K | -- | 205.00K | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 109.00K | 473.00K | 171.00K | 634.00K | |
| Total Current Assets | 8.91M | 7.86M | 15.79M | 16.72M | |
|
|
|||||
| Total Current Assets | 8.91M | 7.86M | 15.79M | 16.72M | |
| Net Property, Plant & Equipment | 288.00K | 359.00K | 470.00K | 510.00K | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 27.84M | 27.84M | 28.04M | 28.04M | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 37.04M | 36.07M | 44.30M | 45.27M | |
|
|
|||||
| Total Accounts Payable | 1.46M | 3.04M | 3.53M | 2.59M | |
| Total Accrued Expenses | 1.20M | 2.15M | 3.46M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 183.00K | 182.00K | 188.00K | 178.00K | |
| Total Finance Division Other Current Liabilities | 1.15M | 1.10M | 2.52M | 3.45M | |
| Total Other Current Liabilities | 1.15M | 1.10M | 2.52M | 3.45M | |
| Total Current Liabilities | 3.99M | 6.47M | 9.70M | 6.22M | |
|
|
|||||
| Total Current Liabilities | 3.99M | 6.47M | 9.70M | 6.22M | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | 79.00K | 163.00K | 192.00K | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 140.00K | 141.00K | 141.00K | 141.00K | |
| Total Liabilities | 4.13M | 6.69M | 10.01M | 6.55M | |
|
|
|||||
| Common Stock & APIC | 147.63M | 135.60M | 133.18M | 133.02M | |
| Retained Earnings | -144.69M | -143.62M | -137.45M | -132.63M | |
| Treasury Stock & Other | 29.92M | 37.34M | 38.48M | 38.20M | |
| Total Common Equity | 32.86M | 29.32M | 34.21M | 38.60M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 32.86M | 29.32M | 34.21M | 38.60M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | 51.00K | 61.00K | 90.00K | 121.00K | |
| Total Equity | 32.91M | 29.38M | 34.30M | 38.72M | |
|
|
|||||